Browse by author
Lookup NU author(s): Dr Matthew Barter,
Professor David YoungORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Osteoarthritis (OA) is a disease typified by the loss of cartilage, the normal integrity of which is maintained by the resident cell, the chondrocyte. Alterations in chondrocyte gene expression with age, injury, loading or predisposing genetics, underpin OA cartilage loss. Cell- and tissue-specific gene expression is determined by epigenetic mechanisms, including DNA methylation, chromatin modifications and non-coding RNAs, including microRNAs and long-non-coding RNAs. A number of epigenetic changes have been identified between OA and normal cartilage, and the enzymes which impart the epigenetic code are increasingly seen as important players in a number of pathologies, including OA. Here, we will describe current and potential new epigenetic studies that are likely to reveal novel aspects of chondrocyte and cartilage biology and potentially help sub-characterise OA phenotypes. Importantly, many of these epigenetic modifiers or non-coding RNAs are proposed drug targets and could represent a therapeutic opportunity for this currently untreatable disease.
Author(s): Barter MJ, Young DA
Publication type: Article
Publication status: Published
Journal: Current Rheumatology Reports
Print publication date: 01/06/2013
Online publication date: 26/07/2013
ISSN (print): 1523-3774
ISSN (electronic): 1534-6307
Altmetrics provided by Altmetric